Hap Trading, LLC Clovis Oncology, Inc. Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$4.06 - $5.8 $1.24 Million - $1.78 Million	-306,454 Reduced 85.02%	54,014 $241,000
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $429,446 - $1.68 Million	109,274 Added 43.5%	360,468 $1.42 Million
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $3.01 Million - $6.02 Million	234,693 Added 1422.3%	251,194 $3.74 Million
Q1 2019 May 10, 2019	BUY	$17.66 - $30.28 $19,002 - $32,581	1,076 Added 6.98%	16,501 $410,000
Q4 2018 Feb 12, 2019	SELL	$11.63 - $32.67 $1,383 - $3,887	-119 Reduced 0.77%	15,425 $277,000
Q3 2018 Nov 09, 2018	BUY	$29.37 - $49.48 $456,527 - $769,117	15,544 New	15,544 $457,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.